Back to dashboard
Episode 40
DIP Episode 40 - Neuro Pharmacology Part 3 (Anesthetics and Opioids)
PharmacologyMedium4 - HighHas Q&A
Step 1Step 2Step 3MedicineUSMLEStep 1Step 2Step 3
Topic
Anesthetic pharmacology (Inhaled, IV, Local), Opioid receptor mechanisms and side effects, Headache syndromes (Tension, Migraine, Cluster), Neuromuscular blo...
Key Takeaway
Understanding the interplay between lipid solubility, blood gas partition coefficient, and MAC is crucial for inhaled anesthetics, while recognizing that opioid agonists cause profound parasympathetic effects (miosis/constipation) and that non-depolarizing neuromuscular blockers require muscarinic antagonism upon reversal.
Runtime: 46.6 min
Published: 2018-07-20
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: NEURO, PHARMACOLOGY
Episode Notes
Source / episode info
- Episode: 40
- Title: Divine Intervention Episode 40 – Neuro Pharmacology Part 3 (Anesthetics and Opioids).
- Published: 2018-07-20
- Source: Episode page
One-liner
This episode covers the pharmacology of inhaled anesthetics (MAC, BG coefficient), IV agents like Propofol/Ketamine, local anesthetic principles (size matters), opioid receptor effects (miosis, constipation), and headache syndromes (Triptans for acute migraine).
High-yield summary
- Inhaled Anesthetics: Low Blood Gas Partition Coefficient -> Quick Onset. Low Minimum Anesthetic Concentration (MAC) -> High Potency/High Lipid Solubility.
- Propofol Infusion Syndrome (PRIS): Associated with Propofol administration, characterized by metabolic acidosis and hyperkalemia.
- Triptans: Used for acute migraine treatment; contraindicated in patients with history of coronary vasospasm or variant angina due to risk of worsening vasoconstriction.
- Opioid Effects: Opioids decrease GI motility, leading to constipation and causing miosis (via decreased sympathetic tone). The exception is myperidine, which is a muscarinic receptor antagonist and causes mydriasis.
- Neuromuscular Blockers (NMB): Non-depolarizing agents are competitive antagonists at nicotinic receptors; reversal with acetylcholinesterase inhibitors (e.g., Neostigmine) requires co-administration of a muscarinic antagonist (e.g., Glycopyrrolate) to prevent parasympathomimetic side effects.
- Headache Syndromes: Cluster headaches are classically unilateral, associated with ipsilateral lacrimation and rhinorrhea ("tearing/runny nose"). Acute treatment is 100% oxygen.
Learning objectives
- Differentiate between the concepts of MAC and Blood Gas Partition Coefficient in inhaled anesthetics.
- Identify the clinical manifestations and management pitfalls associated with Propofol administration.
- Apply knowledge of triptan indications and contraindications in migraine management.
- Explain the mechanism and necessary adjuncts for reversing non-depolarizing neuromuscular blockers.
- Recognize the unique physiological effects (e.g., mydriasis, constipation) of various opioid agonists.
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Propofol Infusion Syndrome (PRIS) | Lactic acidosis + Hyperkalemia | Lipid emulsion infusion | Always suspect PRIS when administering propofol for prolonged periods. |
| Triptan Use in Migraine | Acute treatment only; Vasoconstriction | Coronary vasospasm/Variant Angina | Never give triptans to patients with known coronary artery spasm risk. |
| Non-depolarizing NMB Reversal | Parasympathomimetic effects (SLUDGE) | Acetylcholinesterase Inhibitor + Muscarinic Antagonist | Always pair Neostigmine/Edrophonium with Glycopyrrolate/Atropine. |
| Opioid Overdose | Miosis, Constipation | Respiratory depression | The absence of miosis suggests an overdose on non-opioid agents (e.g., benzodiazepines). |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| Inhaled Anesthetics | Low BG coefficient -> Quick Onset; Low MAC -> High Potency | Gas solubility in blood/lipid membranes | Predicts the speed and required dose of anesthetic agents. |
| Propofol | Lipid emulsion infusion risk | Prolonged use, metabolic acidosis | Requires monitoring for PRIS (lactic acid + hyperkalemia). |
| Triptans | 5-HT_{1 B/2} receptor agonists | Acute migraine attack | Used only acutely; contraindicated in coronary vasospasm. |
| Opioids | Decrease GI motility, cause miosis and constipation | -opioid agonism (e.g., Loperamide) | High yield: Opioids are the primary cause of opioid-induced constipation/miosis. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient undergoing general anesthesia requires rapid induction with minimal drug exposure, suggesting a highly potent agent. | Low MAC/High Lipid Solubility Anesthetic | Potency is inversely related to MAC; high lipid solubility allows rapid crossing of the blood-brain barrier. |
| A patient receiving continuous Propofol infusion develops severe metabolic acidosis and hyperkalemia. | Propofol Infusion Syndrome (PRIS) | PRIS involves a combination of lactic acidosis and hyperkalemia, often requiring discontinuation or dose adjustment. |
| A patient with acute migraine is treated with Sumatriptan but has a history of Prinzmetal angina. | Triptan Contraindication | Triptans are vasoconstrictors; administering them to patients with underlying vasospastic disease (like variant angina) can precipitate an ischemic event. |
| During reversal of non-depolarizing neuromuscular blockade, the patient develops excessive salivation and bronchoconstriction. | Need for Muscarinic Antagonism during Reversal | Acetylcholinesterase inhibitors increase A Ch at both nicotinic and muscarinic receptors; a co-administered anticholinergic (e.g., Glycopyrrolate) is needed to block the resulting parasympathomimetic effects. |
| A patient with severe diarrhea requires an agent that decreases GI motility without causing excessive miosis or sphincter of Oddi spasm. | Loperamide/Opioid Agonist (Myperidine alternative) | Opioids decrease gut motility, treating diarrhea. Myperidine is preferred over other opioids because it does not cause sphincter of Oddi spasm and causes mydriasis. |
| A patient with a suspected opioid overdose presents with respiratory depression and normal pupillary findings. | Benzodiazepine or Barbiturate Overdose | Opioids typically cause miosis; the absence of miosis suggests an overdose on agents like benzodiazepines (e.g., Diazepam) or barbiturates, which are not muscarinic antagonists. |
Differential diagnosis / distinguishing features
Neuromuscular Blockers
| Key Features | Distinguishing Findings | Next Step |
| Non-depolarizing Agents (e.g., Rocuronium) | Competitive antagonism at nicotinic receptors; reversible by A ChE inhibitors. | Reverse with Neostigmine + Glycopyrrolate. |
| Depolarizing Agents (e.g., Succinylcholine) | Acetylcholine receptor agonist; causes initial fasciculations and then block. | Blockade is subject to Phase I/Phase II principles; reversal requires careful monitoring. |
Management pearls
- Propofol Infusion Syndrome: If PRIS is suspected, discontinue Propofol and consider alternative agents (e.g., remifentanil).
- Triptan Use: Always confirm the patient does not have a history of coronary vasospasm or variant angina before administering triptans.
- Opioid Overdose Reversal: Use Naloxone for acute reversal due to its rapid onset; reserve Naltrexone for maintenance/abstinence care.
- Non-depolarizing Blockade Reversal: Never give an acetylcholinesterase inhibitor alone (e.g., Neostigmine) because the resulting muscarinic overstimulation can cause severe bradycardia and bronchospasm.
Don't miss
🚨
The relationship between MAC, lipid solubility, and potency is direct: Low MAC \leftrightarrow High Lipid Solubility \leftrightarrow High Potency.
🚨
Myperidine is a unique opioid agonist because it is also a muscarinic receptor antagonist, leading to mydriasis and preventing sphincter of Oddi spasm.
🚨
The primary mechanism for treating acute migraine involves activating 5-HT_{1 B/2} receptors (Triptans) to induce vasoconstriction.
🚨
When reversing non-depolarizing NM Bs, the addition of a muscarinic antagonist is mandatory to prevent life-threatening parasympathomimetic side effects.
Integration & clinical reasoning
- Pharmacology Integration: The principles governing anesthetic action (lipid solubility, gas laws) are analogous to those seen in drug absorption and distribution across biological barriers (e.g., BBB permeability).
- Endocrine/Neuro Integration: Opioids decrease sympathetic outflow by inhibiting norepinephrine release from nerve terminals, leading to peripheral effects like miosis and decreased GI motility.
- Toxicology Integration: The use of acetylcholinesterase inhibitors in NMB reversal highlights the importance of receptor subtype specificity (nicotinic vs. muscarinic) in pharmacology.
Concept connections / cross-references
- For detailed information on opioid dependence management and partial agonists, see [Episode 39].
- For general principles of autonomic nervous system function and neurotransmitter release, review [Episode 25].
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| Propofol | Propofol Infusion Syndrome (PRIS) | Lipid emulsion infusion leading to metabolic acidosis/hyperkalemia. | Requires careful monitoring and potential dose reduction in prolonged infusions. |
| Triptans | Serotonin 5-HT_{1 B/2} receptor agonists | Induce cerebral vasoconstriction, aborting migraine pain. | Contraindicated in patients with coronary vasospasm (variant angina). |
| Opioids | Miosis and Constipation | Decrease sympathetic outflow -> reduced parasympathetic tone to GI tract. | High yield: These effects are predictable side effects that do not diminish with tolerance. |
| Non-depolarizing NM Bs | Reversal requires muscarinic blockade | A ChE inhibitor increases A Ch at both nicotinic and muscarinic sites. | Must co-administer an anticholinergic (e.g., Glycopyrrolate) to prevent SLUDGE syndrome. |
Key terms glossary
| Term | Definition | Context | Example |
| MAC | Minimum Anesthetic Concentration | The lowest concentration of anesthetic required in the blood to prevent consciousness in 50% of patients. | Low MAC indicates high potency (e.g., Halothane). |
| Blood Gas Partition Coefficient | Ratio of gas solubility in gas phase vs. blood plasma. | Determines how quickly an inhaled agent reaches equilibrium with blood. | Low coefficient means faster onset (e.g., Nitrous Oxide). |
| Propofol Infusion Syndrome (PRIS) | A metabolic complication characterized by lactic acidosis and hyperkalemia. | Prolonged infusion of Propofol lipid emulsion. | Requires discontinuation of the drug or dose reduction. |
| Glycopyrrolate | Muscarinic receptor antagonist. | Used adjunctively when reversing non-depolarizing neuromuscular blockade. | Prevents excessive parasympathomimetic effects (e.g., bradycardia, bronchospasm). |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Anesthetics | Focus on the relationships: MAC Lipid Solubility; BG Coeff Onset. | High | Review tables comparing anesthetic properties (MAC, solubility, onset). |
| Opioids/NM Bs | Master the side effects and reversal mechanisms for both classes of drugs. | Very High | Create flowcharts: Opioid overdose -> Naloxone; NMB reversal -> Neostigmine + Glycopyrrolate. |
| Headache Syndromes | Memorize the classic presentation (unilateral, lacrimation) and specific acute treatments for each type. | Medium-High | Use mnemonics: Cluster = Tearing/Runny Nose; Migraine = Photophobia/Phonophobia. |
Question pattern recognition
- Pharmacology Mechanism: Understanding how a drug works at the receptor level (e.g., agonist vs. antagonist, partial agonism).
- Toxicology/Overdose Management: Identifying the specific antidote or intervention based on the clinical presentation (e.g., Naloxone for opioid overdose; Flumazenil for benzodiazepine overdose).
- Differential Diagnosis: Distinguishing between similar conditions based on unique associated signs and symptoms (e.g., Cluster vs. Migraine headaches).
Test yourself
Common mistakes to avoid
🚫
Mistake 1: Assuming all three Light's criteria must be positive for an exudative effusion. Only one criterion needs to be met (Protein ratio > 0.5 OR LDH ratio > 0.6 OR Pleural LDH > 2/3 ULN).
🚫
Mistake 2: Confusing the role of MAC and BG coefficient. Low MAC relates to potency (lipid solubility); low BG coefficient relates to onset (gas solubility). They are independent concepts.
🚫
Mistake 3: Forgetting that opioid effects persist despite tolerance. Opioid-induced constipation and miosis are side effects that do not diminish with chronic use or tolerance.
Common traps
⚠️
Trap 1: Assuming all inhaled anesthetics have a low MAC (e.g., Halothane has a high BG coefficient but also a high MAC).
⚠️
Trap 2: Giving an acetylcholinesterase inhibitor alone to reverse NM Bs, leading to severe muscarinic side effects.
⚠️
Trap 3: Assuming all opioids cause miosis; forgetting that Myperidine is the exception due to its anticholinergic properties.
OMM / COMLEX integration
🦴
High-Yield Viscerosomatics, Autonomics & COMAT Shelf Clinical Pearls:
- Cranial Nerves & Dura Mater Mechanics: The dura mater attaches firmly to the foramen magnum, C2, C3, and S2 (the reciprocal tension membrane). Craniosacral strains, particularly sphenobasilar synchondrosis (SBS) compression, restrict the cranial rhythmic impulse (normal CRI: 10–14 cycles/min).
- Jugular Foramen & Vagus Nerve Entrapment: The jugular foramen is formed by the petrous portion of the temporal bone and the occiput. Somatic dysfunction here compresses CN IX, X, and XI, leading to autonomic instability, dysphagia, or nausea. Suboccipital decompression frees the occipitoatlantal (OA) joint and improves CSF/venous drainage.
- Cervical Radiculopathy vs. Thoracic Outlet: In upper extremity neurological symptoms, differentiate cervical nerve root impingement (Spurling test) from thoracic outlet syndrome caused by tight anterior/middle scalenes (elevating rib 1) or pectoralis minor hypertonicity.